BIOCHEMICAL SOCIETY TRANSACTIONS phonic analogue is not recognized. These collected findings are consistent with recent crystallographic and chemical studies on the active site of the enzyme (Sandmeier & Christen, 1982; Arnone et al., 1984; Kirsch et al., 1984) : the substrate specificity is largely determined by the interactions of a-and o-carboxylate groups with guanidinium groups of Arg-386 and Arg-292, respectively. The binding of the two carboxylate groups induces a conformational change of the protein, and the &-amino group of Lys-258 which binds the coenzyme can act as C,-H proton acceptor. It may be assumed -that the replacement of one of the carboxylate groups induces restrictions in such conformational changes, leading to a decrease in reactivity of the effector. Distinctions in cytosolic and mitochondria1 isozymes with respect to the distances between the two arginyl residues and the lysyl 258 Schiff's base, and/or the degree of freedom of the rotation of these active site components (Iriarte et al., 1984) could explain the different data observed for Asp-p-P and Glu-y-P with the two isozymes.
The present results relative to the aminomalonate analogue and Asp-P-P, which are both substrates and inhibitors, show the importance of an a-carboxylic group in the binding of an effector with the ASAT active site. As there is much less information available about the degradation in vivo of pure G-11, in the present work, the true digestibility in vivo of a highly purified G-11 preparation was studied in rats.
G-I1 was isolated from seeds of P. vulgaris as before (Pusztai & Watt, 1970) . The amount of lectin contamination was reduced to less than 0.3% by affinity chromaAbbreviation used: G-11, glycoprotein 11. tography on Sepharose 4B-fetuin. It was thought unlikely that the results would be influenced unduly by the presence of such a small amount of toxic component.
Rats fasted for 16 h were given an intragastric dose of 300 mg of G-II(45 mg N ) and then fed a protein-free diet, ad lib, for 3 days. Faeces were collected daily and N estimated. Faeces were also extracted with 0.025 M-glycine/Tris buffer, pH 8.6 (3-5 mg of faeces/ml of buffer) and the concentration of G-11-related material was estimated by rocket immunoelectrophoresis. This was based upon previous observation (R. Begbie, unpublished work) that the fragment derived from the partial digestion of G-11 retained full reactivity with anti-G-11 antibodies.
It was found that (Fig. l a ) the faeces contained more than 50 mg of total N although only 45 mg of G-11 N had been introduced into the stomach. The faecal N comprised approx. 12 mg of G-11 N. The remainder, about 38 mg, was unrelated to (3-11, indicating that 74% of the G-11 was degraded during passage through gastrointestinal tract. The bulk (8 mg) of the partially digested G-11 N appeared in the faeces in the first 24 h, while the output of N unrelated to G-I1 peaked on the second day. It appears that by an unknown mechanism, the native G-11 and/or its fragments may have stimulated an increased secretion of endogenous metabolic N.
Since proteolysis by bacteria in the large intestine may have made appreciable contributions to degradation of G-11 without nutritionally benefiting the rat, in another series of experiments rats were given an intragastric dose of 150 mg of G-I1 (22.5 mg N) and killed after 1 h. Both stomach and small intestine were removed and their contents washed out. The tissues were then homogenized in phosphate buffer containing aprotinin (5 mg tissue/ml of buffer) and centrifuged.
After correction for the control (rats given an intragastric 625th MEETING, LONDON dose of saline), the total amount o f N found in the luminal contents and tissue homogenates was at least as much (23.4 f 0.8 mg) as in the G-II input. On the other hand, the amount of G-11-related N recovered from the small intestine was only 9.6 k 0.8 mg, indicating that about 57"/0 of the G-II was degraded and absorbed within 1 h. Moreover, a large proportion (about 60%) of the surviving G-11-related protein was found to be strongly associated with small intestinal tissue (Fig. 1 b ) and was released only on homogenization.
In conclusion, at least 57% of G-II was degraded in the small intestine within 1 h. During the remaining time ( = 1 h) in the small intestine and then in the large intestine, G-II was further degraded. The core-polypeptide fragments of 22-30 kDa surviving in the small intestine showed a similar subunit pattern by SDS/polyacrylamide gel electrophoresis (PAGE) to that observed on degradation in vitro (Deshpande & Nielsen, 1987) . As the extent of degradation of G-II in vivo (74%) exceeds that obtained in vitro by pure endopeptidases (2%), the results strongly suggest the involvement of additional proteinases in the breakdown of G-II in the gut. The strong attachment of G-I1 to the intestinal tissue and extended exposure time to proteolytic enzymes may further aid this digestive process. However, an appreciable part (about 26%) of the dietary G-II escapes digestion in the whole alimentary tract. The reasons for this may be related to the previously observed microheterogeneity of G-II (Pusztai & Stewart, 1980) or partial protection from proteolysis by an unknown mechanism.
Finally the large difference between apparent and true digestibility values indicates that G-II and/or its fragments are stimulants of secretion of endogenous N (mucus, etc.) in the small intestine.
